Sökning: L773:1876 2891 > Alteration of the i...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 02984naa a2200397 4500 | |
001 | oai:DiVA.org:oru-35263 | |
003 | SwePub | |
008 | 140605s2014 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-352632 URI |
024 | 7 | a https://doi.org/10.3920/BM2013.00332 DOI |
040 | a (SwePub)oru | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a König, Julia,d 1983-u Örebro universitet,Institutionen för hälsovetenskap och medicin,NGBI4 aut0 (Swepub:oru)jkg |
245 | 1 0 | a Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome |
264 | 1 | b Wageningen Academic Publishers,c 2014 |
338 | a print2 rdacarrier | |
520 | a The intestinal microbiota forms a complex ecosystem that is in close contact with its host and has an important impact on health. An increasing number of disorders are associated with disturbances in this ecosystem. Also patients suffering from irritable bowel syndrome (IBS) show an altered composition of their gut microbiota. IBS is a multifactorial chronic disorder characterised by various abdominal complaints and a worldwide prevalence of 10-20%. Even though its aetiology and pathophysiology are complex and not well understood, it is widely accepted that aberrations along the microbe-gut-brain axis are involved. In this review, it will be discussed how exogenous factors, e.g. antibiotics, can cause disbalance in the intestinal microbiota and thereby contribute to the development of IBS. In addition, several new IBS treatment options that aim at re-establishing a healthy, beneficial ecosystem will be described. These include antibiotics, probiotics, prebiotics and faecal transplantation. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Näringslära0 (SwePub)303042 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nutrition and Dietetics0 (SwePub)303042 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Mikrobiologi inom det medicinska området0 (SwePub)301092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Microbiology in the medical area0 (SwePub)301092 hsv//eng |
653 | a gut microbiota | |
653 | a antibiotics | |
653 | a probiotics | |
653 | a prebiotics | |
653 | a faecal transplantation | |
653 | a Biomedicin | |
653 | a Biomedicine | |
700 | 1 | a Brummer, Robert-Jan,d 1957-u Örebro universitet,Institutionen för läkarutbildning,Region Örebro län,NGBI4 aut0 (Swepub:oru)rnbr |
710 | 2 | a Örebro universitetb Institutionen för hälsovetenskap och medicin4 org |
773 | 0 | t Beneficial Microbesd : Wageningen Academic Publishersg 5:3, s. 247-261q 5:3<247-261x 1876-2883x 1876-2891 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-35263 |
856 | 4 8 | u https://doi.org/10.3920/BM2013.0033 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.